Korenjak Boštjan, Tratenšek Armando, Arko Matevž, Romolo Anna, Hočevar Matej, Kisovec Matic, Berry Maxence, Bedina Zavec Apolonija, Drobne David, Vovk Tomaž, Iglič Aleš, Nemec Svete Alenka, Erjavec Vladimira, Kralj-Iglič Veronika
University of Ljubljana, Faculty of Health Sciences, Laboratory of Clinical Biophysics, SI-1000 Ljubljana, Slovenia.
University of Ljubljana, Faculty of Pharmacy, SI-1000 Ljubljana, Slovenia.
Cells. 2024 Dec 12;13(24):2054. doi: 10.3390/cells13242054.
Extracellular nanoparticles (EPs) are a subject of increasing interest for their biological role as mediators in cell-cell communication; however, their harvesting and assessment from bodily fluids are challenging, as processing can significantly affect samples. With the aim of minimizing processing artifacts, we assessed the number density () and hydrodynamic diameter () of EPs directly in diluted plasma and blood using the following recently developed technique: interferometric light microscopy (ILM). We analyzed 613 blood and plasma samples from human patients with inflammatory bowel disease (IBD), collected in trisodium citrate and ethylenediaminetetraacetic acid (EDTA) anticoagulants, and 163 blood and plasma samples from canine patients with brachycephalic obstructive airway syndrome (BOAS). We found a highly statistically significant correlation between in the plasma and in the blood only in the human (i.e., but not canine) blood samples, between the samples with trisodium citrate and EDTA, and between the respective for both species (all < 10). In the human plasma, the average <> was 139 ± 31 nm; in the human blood, <> was 158 ± 11 nm; in the canine plasma, <> was 155 ± 32 nm; and in the canine blood, <> was 171 ± 33 nm. The differences within species were statistically significant ( < 10), with sufficient statistical power (P > 0.8). For <>, we found no statistically significant differences between the human plasma and blood samples or between the samples with trisodium citrate and EDTA. Our results prove that measuring and of EPs in minimally processed fresh blood and in diluted fresh plasma by means of ILM is feasible for large populations of samples.
细胞外纳米颗粒(EPs)作为细胞间通讯介质的生物学作用日益受到关注;然而,从体液中获取和评估它们具有挑战性,因为处理过程会对样本产生显著影响。为了尽量减少处理伪像,我们使用以下最近开发的技术:干涉光显微镜(ILM),直接在稀释的血浆和血液中评估EPs的数量密度()和流体动力学直径()。我们分析了613份来自炎症性肠病(IBD)人类患者的血液和血浆样本,这些样本采集于柠檬酸钠和乙二胺四乙酸(EDTA)抗凝剂中,以及163份来自短头阻塞性气道综合征(BOAS)犬类患者的血液和血浆样本。我们发现,仅在人类(而非犬类)血液样本中,血浆中的和血液中的之间存在高度统计学显著相关性,在柠檬酸钠和EDTA样本之间以及两种物种各自的之间也存在高度统计学显著相关性(所有<10)。在人类血浆中,平均<>为139±31nm;在人类血液中,<>为158±11nm;在犬类血浆中,<>为155±32nm;在犬类血液中,<>为171±33nm。物种内的差异具有统计学显著性(<10),具有足够的统计效力(P>0.8)。对于<>,我们发现人类血浆和血液样本之间或柠檬酸钠和EDTA样本之间没有统计学显著差异。我们的结果证明,通过ILM在最少处理的新鲜血液和稀释的新鲜血浆中测量EPs的和对于大量样本是可行的。